On 2 February 2026, Parkway Life REIT (“PLife”) released their full year result for FY2025. While the long-term trajectory of year-on-year growth was maintained, the quarter-on-quarter DPU performance faced moderate downward pressure.
This decline was primarily driven by a disproportionate rise in trust expenses and financing costs, which outpaced organic revenue growth during the period. Management has disclosed that the increase in trust expenses was temporarily inflated by one-off professional fees associated with the structural optimization of the four newly acquired French assets. Whereas finance costs drifted higher due to the full-quarter impact of debt-funded capital expenditures and the Japan acquisitions.
Do note that the operating environment remains shadowed by significant macroeconomic shifts in Japan. The Bank of Japan has raised interest rates to historic levels in December 2025. They have also raised growth estimates and signalled a persistent “hawkish” stance. A sustained high-interest-rate environment in Japan could lead to a higher “all-in” cost of debt upon the refinancing of maturing tranches, which will in turn weigh down on DPU over the next few quarters.
Disclaimer: Not financial advice. This content is provided for general informational purposes only and does not constitute financial, investment, legal, or tax advice. The information presented is based on publicly available data and estimates that may be subject to change without notice. It does not take into account your individual financial situation, investment objectives, risk tolerance, or specific needs.
Website: Financial Statements And Related Announcement::Full Yearly Results
Photo source: https://fifthperson.com/2021-parkway-life-reit-agm/
Financial Highlights
Distribution Per Unit (“DPU”)
| Metrics | Current | Previous |
|---|---|---|
| Distribution Per Unit | -4.6% | +2.6% |
| Rating | Unfavourable | Favourable |
The DPU metric will be assessed on a quarterly basis given the information available from the business updates.
For PLife, DPU disclosed are as follows:
- Fourth Quarter of FY2025: SGD0.0373 per unit
- Third Quarter of FY2025: SGD0.0391 per unit
- Second Quarter of FY2025: SGD0.0381 per unit
- First Quarter of FY2025: SGD0.0384 per unit
DPU for the fourth quarter of FY2025 has decreased by 4.6% to SGD0.0373 per unit from SGD0.0391 per unit in the previous quarter. The decrease in DPU was mainly due to increase in finance costs and trust expenses, as noted that net property income when offset with net changes in fair value of financial derivatives remain relatively unchanged. This metric has shifted towards Unfavourable.
Occupancy
| Metrics | Current | Previous |
|---|---|---|
| Occupancy | 98.6% | 99.4% |
| Rating | Favourable | Favourable |
The occupancy metric will be assessed on a quarterly basis given the information available from the business updates.
Based on the announcement on 2 February 2026, overall occupancy was not included in the business update for the fourth quarter of FY2025.
For this quarter assessment, the floor area will be used instead of appraised value in the previous quarter to align with general industry practices.
For PLife, occupancy and floor area by portfolio is provided as below:
- Singapore: Committed Occupancy 100.0%, Floor Area 118,136 square meter
- Japan: Committed Occupancy 97.7%, Floor Area 247,246 square meter
- France: Committed Occupancy 100.0%, Floor Area 42,631 square meter
Using the above information, the overall occupancy is estimated by allocating the respective portfolio committed occupancy based on their proportionate floor area. Do note that this is an estimation that may defer from management’s calculations.
Occupancy rate as of 31 December 2025 has decreased to 98.6%. This metric remains Favourable as it is significantly above my expected healthy occupancy rate of 95%.
Gearing Ratio
| Metrics | Current | Previous |
|---|---|---|
| Gearing Ratio | 33.4% | 35.8% |
| Rating | Favourable | Favourable |
The gearing ratio metric will be assessed on a quarterly basis given the information available from the business updates.
Gearing ratio as of 31 December 2025 has decreased to 33.4%. This was mainly contributed by a decrease in borrowings, as noted that the debt balance as of 31 December 2025 amounted to SGD886.2 million compared to SGD934.2 million in the previous quarter. This metric remains Favourable.
Interest Coverage
| Metrics | Current | Previous |
|---|---|---|
| Interest Coverage | 8.6x | 8.9x |
| Rating | Favourable | Favourable |
The interest coverage metric will be assessed on a quarterly basis given the information available from the business updates.
The interest coverage as of 31 December 2025 has decreased to 8.6 times. This metric remains Favourable as it is significantly higher than my preference of 3.0 times. This is attributable to their reported low cost of debt of 1.59% as their loans and borrowings are mainly Japanese Yen denominated.
Do note that the cost of debt is on an uptrend and may continue to increase due to policies by the Bank of Japan.
The Bank of Japan on 19 December 2025 have raised short-term interest rates to levels unseen in three decades to 0.75% from 0.50% in the first increase since 24 January 2025. The move underscored the central bank’s conviction that Japan was on course to stably hit its 2% inflation target backed by wage gains, and ready for a continued normalisation of monetary policy.
Website: Bank of Japan raises interest rates to 30-year high, signals more hikes
The Bank of Japan on 23 January 2026 have kept interest steady, although its growth estimate was raised and maintained the hawkish inflation forecasts.
Website: Bank of Japan keeps rates steady, raises growth and inflation forecasts
Debt maturity profile
| Metrics | Current | Previous |
|---|---|---|
| Debt Maturity Profile | 3.0 years | 3.3 years |
| Rating | Favourable | Favourable |
The debt maturity profile metric will be assessed on a quarterly basis given the information available from the business updates.
The weighted average term to maturity of their debt as of 31 December 2025 has shortened to 3.0 years. This metric remains Favourable as there is sufficient time for the REIT to refinance their debts as they fall due. Do note that 36% of their debt due to mature by the end of FY2027.
Price to Book Ratio
| Metrics | Current | Previous |
|---|---|---|
| Price to Book Ratio | 1.58 | 1.68 |
| Rating | Unfavourable | Unfavourable |
The price to book ratio metric will be assessed on a quarterly basis given the information available from the business updates and the most recent share price is available on a daily basis.
The Price to Book (“P/B”) ratio has become cheaper at 1.58. This is computed using the closing share price of SGD4.04 per unit on 20 February 2026 and the net asset value of SGD2.56 per unit as of 31 December 2025. The P/B ratio remains Unfavourable.
While the stock appears grossly overvalued, it could continue to trade at a premium. This dynamic is detailed further under ‘Key Things to Note.
As of 20 February 2026, the Market Capitalization is approximately SGD2,636 million.
Website: Yahoo Finance: Parkway Life Real Estate Investment Trust (C2PU.SI)
Dividend
| Year | Yield | Total |
|---|---|---|
| 2026 | 1.89% | SGD 0.076 |
| 2025 | 2.48% | SGD 0.100 |
| 2024 | 4.96% | SGD 0.200 |
| 2023 | 3.62% | SGD 0.146 |
| 2022 | 2.63% | SGD 0.106 |
| 2021 | 3.49% | SGD 0.141 |
The calendar year 2024 dividend pay-out was elevated by a one-off advance distribution of SGD0.050 per unit, issued in conjunction with the year’s equity fundraising. If this advance is reallocated to the calendar year 2025, the dividend for both years normalizes to approximately SGD0.150 per unit. This estimation will be used as it is a more conservative estimate, maintaining consistency with the stable projections.
With the closing share price of SGD4.04 per unit on 20 February 2026, this translates to a dividend yield of 3.71%. For my benchmark, a reasonable yield would be around 4.75%. PLife yield sounds similar to growth equity stocks from other industries. The dividend yield is Unfavourable.
Website: Reasonable Dividend Yield 2026Q1 – 4.75%
Nonetheless, there is an interesting rationale for the dividend yield to be compressed and will be covered more in the “Key Things to Note” section.
Key Things to Note
Expensive getting more expensive
PLife is a relatively more expensive REIT compared to others that are available in the market. A dividend yield of 3.71% and P/B ratio of 1.58 exposes investors to higher risks. Given the straightforward business of REITs, their fair value usually should trade around their net asset value.
The key thing to note however, unlike most other REITs, PLife have income visibility. With their 20 years lease, this contributes a substantial portion of their income and serves as a bulwark for PLife as they explore new initiatives. Not to mention that this lease agreement also takes into consideration the Consumer Price Index (“CPI”) and is designed to increase overall rent payable based on the CPI. This is an effective hedge against inflation, which has been breaking historic highs recently.
Based on its dividend records, we can also see that they have steadily increase dividend pay-out over the years. Its stability and transparency are the reason for its high premium.
Nonetheless, it is still expensive, and something that investors should take note off and decide if they are comfortable with it before investing. If the market decides to crash, PLife’s can easily lose a significant portion of its market value.
Tenant concentration
Parkway Hospitals Singapore Pte. Ltd. remains the lead tenant, accounting for 60.8% of gross revenue. While a 20-year lease renewal provides long-term visibility, this high level of tenant concentration exposes the REIT to significant counterparty risk. As businesses face tightening cash flows, rental expenses are often targeted for cost-cutting. Any deterioration in the tenant’s financial position could, therefore, adversely impact the REIT’s DPU moving forward.
While the revenue concentration in Parkway Hospitals Singapore Pte. Ltd. presents a significant single-tenant risk, this is partially mitigated by the credit strength of its parent company, IHH Healthcare Berhad.
Website: IHH Healthcare Financial Highlights
IHH Healthcare Berhad is also backed by major institutional shareholders, including Mitsui & Co. and Malaysia’s sovereign wealth fund, Khazanah Nasional. The tenant benefits from robust financial oversight and deep capital reserves. This high-tier institutional support provides a safety net against the broader trend of tightening corporate cash flows, lending further credibility to the stability of the 20-year lease agreement.
Summary
| Metrics | Financials | Rating |
|---|---|---|
| Distribution Per Unit | -4.6% | Unfavourable |
| Occupancy | 98.6% | Favourable |
| Gearing Ratio | 33.4% | Favourable |
| Interest Coverage | 8.6x | Favourable |
| Debt Maturity Profile | 3.0 years | Favourable |
| Price to Book Ratio | 1.58 | Unfavourable |
| Overall | Neutral |
Overall, PLife metrics shifted towards Neutral. For a final look at the overarching strategy, I recommend a quick reread of the summary and overall outlook provided in the opening paragraphs.
Background
PLife is one of Asia’s largest listed healthcare Real Estate Investment Trusts (“REIT”). It invests in income-producing real estate and real estate related assets that are used primarily for healthcare and healthcare-related purposes (including, but not limited to, hospitals, nursing homes, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices).
It owns the largest portfolio of strategically located private hospitals in Singapore comprising Mount Elizabeth Hospital, Gleneagles Hospital and Parkway East Hospital. In addition, it has high-quality nursing home and care facility properties across various prefectures in Japan, as well as strategically located nursing homes in France. Managed by Parkway Trust Management Limited, PLife REIT has been listed on the Mainboard of the Singapore Stock Exchange since August 2007.
Previous Post
Website: Parkway Life REIT (SGX: C2PU): 2025 Third Quarter Business Update
